Your browser doesn't support javascript.
Complement C5 inhibition in patients with COVID-19 - a promising target?
Peffault de Latour, Regis; Bergeron, Anne; Lengline, Etienne; Dupont, Thibault; Marchal, Armance; Galicier, Lionel; de Castro, Nathalie; Bondeelle, Louise; Darmon, Michael; Dupin, Clairelyne; Dumas, Guillaume; Leguen, Pierre; Madelaine, Isabelle; Chevret, Sylvie; Molina, Jean-Michel; Azoulay, Elie; Fremeaux-Bacchi, Veronique.
  • Peffault de Latour R; Saint Louis Hospital.
  • Bergeron A; Saint-Louis Hospital.
  • Lengline E; Saint-Louis Hospital.
  • Dupont T; Saint-Louis Hospital.
  • Marchal A; HEGP Hospital.
  • Galicier L; Saint-Louis Hospital.
  • de Castro N; Saint-Louis Hospital.
  • Bondeelle L; Saint Louis Hospital.
  • Darmon M; Saint-Louis University Hospital.
  • Dupin C; Saint Louis Hospital.
  • Dumas G; Saint Louis Hospital.
  • Leguen P; Saint Louis Hospital.
  • Madelaine I; Saint Louis Hospital.
  • Chevret S; Saint Louis Hospital.
  • Molina JM; Saint Louis Hospital.
  • Azoulay E; Saint Louis Hospital.
  • Fremeaux-Bacchi V; HEGP Hospital.
Haematologica ; 105(12): 2847-2850, 2020 12 01.
Article in English | MEDLINE | ID: covidwho-676578

Full text: Available Collection: International databases Database: MEDLINE Main subject: Complement C5 / Complement Inactivating Agents / Antibodies, Monoclonal, Humanized / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Prognostic study Limits: Humans Language: English Journal: Haematologica Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Complement C5 / Complement Inactivating Agents / Antibodies, Monoclonal, Humanized / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Prognostic study Limits: Humans Language: English Journal: Haematologica Year: 2020 Document Type: Article